A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2002
12/12/2002	CA2448427A1 Molecules and methods for inhibiting shedding of kim-1
12/12/2002	CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	CA2448384A1 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
12/12/2002	CA2448382A1 Use of hepcidin as a regulator of iron homeostasis
12/12/2002	CA2448282A1 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002	CA2448250A1 Limks as modifiers of the p53 pathway and methods of use
12/12/2002	CA2448112A1 Lces as modifiers of the p53 pathway and methods of use
12/12/2002	CA2448107A1 Marks as modifiers of the p53 pathway and methods of use
12/12/2002	CA2448044A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof
12/12/2002	CA2447935A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
12/12/2002	CA2447732A1 Antineoplastic combinations
12/12/2002	CA2447695A1 Modified antibodies to prostate-specific membrane antigen and uses thereof
12/12/2002	CA2446719A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
12/12/2002	CA2443850A1 Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors
12/12/2002	CA2436408A1 Modified psma ligands and uses related thereto
12/12/2002	CA2430697A1 Atp-binding cassette transporter-like molecules and uses thereof
12/11/2002	EP1264889A1 Chicken leukemia inhibitory factor (LIF) and the gene thereof
12/11/2002	EP1264887A1 Novel armadillo repeat-containing protein alex1
12/11/2002	EP1264884A1 Method of controlling telomere length
12/11/2002	EP1264831A1 Cell division inhibitors and process for producing the same
12/11/2002	EP1264828A1 New inhibitor of urokinase
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264821A1 Novel crystal of stilbene derivative and process for producing the same
12/11/2002	EP1264598A1 Altering an immune response by influencing the interaction of LAIR with its ligand
12/11/2002	EP1264597A2 Methods and compositions for treating cancer
12/11/2002	EP1263982A1 Phosphatidyl serine receptors and uses thereof
12/11/2002	EP1263960A2 Anti-tissue factor antibodies with enhanced anticoagulant potency
12/11/2002	EP1263959A1 Antibodies to human cd154
12/11/2002	EP1263958A2 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
12/11/2002	EP1263956A2 Human genes and gene expression products
12/11/2002	EP1263955A2 Polypeptides and nucleic acids encoding same
12/11/2002	EP1263948A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2002	EP1263940A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263928A1 Cytotoxic t lymphocytes activated by dendritic cell hybrids
12/11/2002	EP1263803A1 Embolic compositions
12/11/2002	EP1263791A2 Human g-protein chemokine receptor (ccr5) hdgnr10
12/11/2002	EP1263787A2 G-protein coupled receptors
12/11/2002	EP1263786A2 Methods and compositions for immunoregulation
12/11/2002	EP1263785A2 Mutated il-13 molecules and their uses
12/11/2002	EP1263784A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
12/11/2002	EP1263780A2 Liv-1 related protein, polynulceotides encoding the same and use thereof for treatment of cancer
12/11/2002	EP1263779A1 Self antigen vaccines for treating b cell lymphomas and other cancers
12/11/2002	EP1263776A2 Peptides targeting specifically tumor-derived endothelial cells
12/11/2002	EP1263775A1 Hla binding peptides and their uses
12/11/2002	EP1263767A2 Beta netrin and uses thereof
12/11/2002	EP1263766A1 Adam polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263765A1 ALTERATION OF CELLULAR BEHAVIOR BY ANTISENSE MODULATION OF mRNA PROCESSING
12/11/2002	EP1263763A2 Tubulin binding ligands and corresponding prodrug constructs
12/11/2002	EP1263761A2 Compounds for pdt
12/11/2002	EP1263760A1 Novel compounds
12/11/2002	EP1263759A2 Azaindoles
12/11/2002	EP1263757A1 Benzthiazoles as tnf and pde-iv inhibitors
12/11/2002	EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263753A1 Imidazol derivatives as raf kinase inhibitors
12/11/2002	EP1263752A2 Lpa receptor agonists and antagonists and methods of use
12/11/2002	EP1263749A1 Taxane anticancer agents
12/11/2002	EP1263741A1 Bifunctional chelating agent
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263728A2 Pde iv inhibiting amides, compositions and pharmaceutical use
12/11/2002	EP1263725A1 Novel compounds
12/11/2002	EP1263724A1 Novel compounds
12/11/2002	EP1263723A1 Ningalin b analogs employable for reversing multidrug resistance
12/11/2002	EP1263722A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
12/11/2002	EP1263721A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
12/11/2002	EP1263720A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
12/11/2002	EP1263719A1 N-deacetylthiocolchine derivatives and pharmaceutical compositions containing them
12/11/2002	EP1263718A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1263715A1 Novel phenylheteroalkylamine derivatives
12/11/2002	EP1263475A2 Synthetic oligonucleotides as inducers of erythroid differentiation
12/11/2002	EP1263474A1 A method of sensitising endothelial cells to prodrugs
12/11/2002	EP1263473A2 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use
12/11/2002	EP1263472A2 Modification of biopolymers for improved drug delivery
12/11/2002	EP1263469A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues
12/11/2002	EP1263468A1 Formulation solubilizing water-insoluble agents and preparation method thereof
12/11/2002	EP1263465A2 Photodynamic cellular and acellular organism eradication using a photosensitive material and surfactant
12/11/2002	EP1263464A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function
12/11/2002	EP1263463A1 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cells
12/11/2002	EP1263456A2 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"
12/11/2002	EP1263452A2 Methods and compositions for generating angiostatin
12/11/2002	EP1263447A1 Optically-active nanoparticles for use in therapeutic and diagnostic methods
12/11/2002	EP1263446A2 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
12/11/2002	EP1263443A1 Metalloproteinase inhibitors for the treatment of respiratoty diseases
12/11/2002	EP1263440A2 Cephalotaxine alkaloid combination compositions and uses thereof
12/11/2002	EP1263437A2 Farnesyl protein transferase inhibitor combinations with vinca alkaloids
12/11/2002	EP1263436A1 Use of glucosylceramide synthesis inhibitors in brain cancertherapy
12/11/2002	EP1263431A1 Condensation derivatives of thiocolchicine and baccatin as antitumor agents
12/11/2002	EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
12/11/2002	EP1263422A1 Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (copd)
12/11/2002	EP1263419A2 Compounds capable of binding with the cytoskeleton
12/11/2002	EP1263414A1 Pharmaceutical compositions of glycogen phosphorylase inhibitors
12/11/2002	EP1071433B1 2',2'-difluoronucleosides for immunosuppressive therapy and combined pharmaceutical compositions
12/11/2002	EP1056716B1 Cyclohexanediole derivatives
12/11/2002	EP1051421B1 Compounds containing boron for electron microscopy and for boron neutron-capture therapy
12/11/2002	EP0859630B1 Combination of temozolomide and alpha-ifn for the treatment of advanced cancer
12/11/2002	EP0820289B1 Trapidil for use in the treatment of immuno-modulatorily influencible cases
12/11/2002	EP0807185B9 Antitumor preparations containing a lipoteichoic acid from steptococcus
12/11/2002	EP0802985B1 Cell cycle regulated repressor and dna element
12/11/2002	EP0722446B1 Distamycin a analogues as antitumour or antiviral agents
12/11/2002	EP0662958B1 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistent cancer cell sensitizers

1 ... 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 ... 2211